Shield Therapeutics plc (AIM:STX)
London · Delayed Price · Currency is GBP · Price in GBX 4.910
+0.010 (0.20%)
Aug 21, 2026, 3:59 PM GMT
Shield Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -17.66 | -27.18 | -33.29 | -49.79 | -26.65 |
Depreciation & Amortization | 0.37 | 0.71 | 0.37 | 2.12 | 2.19 |
Other Amortization | 0.75 | 0.71 | 0.71 | 0.74 | 0.8 |
Asset Writedown & Restructuring Costs | - | - | - | 18.11 | - |
Stock-Based Compensation | 0.79 | 0.86 | 0.88 | 0.91 | 1.34 |
Other Operating Activities | 7.2 | 3.55 | 1.25 | 1.4 | 0.01 |
Change in Accounts Receivable | -8.65 | -1.14 | -7.01 | -2.79 | -3.9 |
Change in Inventory | -3.43 | -2.46 | -1.45 | 0.22 | -0.35 |
Change in Accounts Payable | 16.76 | 10.47 | 1.91 | 7.27 | 2.69 |
Change in Other Net Operating Assets | 0.5 | 7.71 | -0.48 | -0.78 | -0.87 |
Operating Cash Flow | -3.38 | -6.77 | -37.13 | -22.59 | -24.73 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.02 | -0.04 | -0.24 | -0.06 | -0.5 |
Sale (Purchase) of Intangibles | -0.28 | -2.39 | -2.71 | -2.22 | -2.29 |
Other Investing Activities | 0.09 | 0.27 | 0.52 | 0.04 | 0.02 |
Investing Cash Flow | -0.21 | -2.16 | -2.43 | -2.25 | -2.78 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | 1.71 | 5.7 | 29.45 | 9.08 | - |
Long-Term Debt Repaid | -0.2 | -0.21 | -5.99 | -0.15 | -0.1 |
Net Debt Issued (Repaid) | 1.51 | 5.49 | 23.45 | 8.93 | -0.1 |
Issuance of Common Stock | 11.95 | 0.12 | 26.82 | 0.11 | 37.51 |
Other Financing Activities | -4.84 | -4.18 | -0.61 | -0.5 | 0.11 |
Financing Cash Flow | 8.63 | 1.43 | 49.66 | 8.53 | 37.52 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | 0.06 | 0.07 | 0.45 | -1.13 | 2.41 |
Miscellaneous Cash Flow Adjustments | - | - | - | 4.5 | - |
Net Cash Flow | 5.1 | -7.42 | 10.55 | -12.94 | 12.43 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.4 | -6.81 | -37.37 | -22.66 | -25.23 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -6.85% | -21.15% | -285.56% | -411.98% | -1226.73% |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.05 | -0.10 | -0.12 |
Levered Free Cash Flow | 6.24 | -12.05 | -28.96 | -12.7 | -17.68 |
Unlevered Free Cash Flow | 10.88 | -9.63 | -28.33 | -12.45 | -17.68 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 4.84 | 3.95 | 0.61 | 0.4 | 0.06 |
Cash Income Tax Paid | 0.41 | 0.76 | 0.72 | -0.71 | -0.8 |
Change in Working Capital | 5.17 | 14.58 | -7.02 | 3.93 | -2.43 |